6003 ORAL Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in relapsed diffuse large B-cell lymphoma (DLBCL)

Autor: Crump, M., Coiffier, B., Jacobsen, E.D., Sun, L., Ricker, J.L., Xie, H., Frankel, S.R., Randolph, S.S., Cheson, B.D.
Zdroj: In EJC Supplements 2007 5(4):346-346
Databáze: ScienceDirect